Lexington Biosciences Inc. (LXGTF)

[gopherdat]

15 years as an Independent Health Insurance Broker and currently contract with over 70 Insurance companies. Over the years I have contracted with many more. Being in health insurance, it is not only my job understanding all aspects of the reimbursement process but in the pre-authorization of services as well. Which in this many times requires working with Healthcare providers also.
From past filings with Lex, they have been working on reimbursement for some time and as such I am anticipating that reimbursement will be accomplished shortly after FDA clearance.
Medicare will play a huge role in the sales & use of the HS IMO. Most all of my business is with Medicare age clients so I do contract with CMS and have a thorough understanding of their procedures.
I feel we will see a significant increase with the completion of the trials and submitting to FDA with a slow and steady climb while waiting for clearance.
Clearance I believe will bring the largest increase we have seen thus far.
I feel they will contract the sales to providers with a major medical supplier and hopefully with more than one.
I feel when the news hits of contracts we will again see a significant increase in SP at that point.
As you are indicating though, the biggest jump will come from HS actually being sold & in use with potential dividends on the horizon, with the fullest potential of the SP being realized from actual dividends being paid to us common share holders. (IMO also)
70% of my business hits Oct. 15th & runs to Dec. 7th so soon I won't be able to do much of anything else but work.
Best wishes to us all for a rebound this week.